Diabetic ketoacidosis and electroencephalographic changes in newly diagnosed pediatric patients

Mark T Mackay1, Charlotte Molesworth2, Elisabeth A Northam3,4

  • 1Department of Neurology, Royal Children's Hospital, Melbourne, Victoria, Australia.

Pediatric Diabetes
|June 18, 2015
PubMed

Insights

Electroencephalogram (EEG) changes in children with new-onset type 1 diabetes mellitus (T1DM) and diabetic ketoacidosis (DKA) show brain dysfunction at diagnosis. However, EEG findings at diagnosis do not predict long-term cognitive deficits.

Area of Science:

  • Pediatric Neurology
  • Endocrinology
  • Neurophysiology

Background:

  • Type 1 diabetes mellitus (T1DM) is an autoimmune disease affecting children.
  • Diabetic ketoacidosis (DKA) is a serious complication of T1DM.
  • Brain dysfunction can occur in pediatric T1DM, particularly with DKA.

Purpose of the Study:

  • To document electroencephalogram (EEG) changes in newly diagnosed pediatric T1DM patients.
  • To correlate EEG findings with clinical parameters, especially in the presence of DKA.
  • To assess the medium-term utility of EEG in predicting cognitive outcomes.

Main Methods:

  • A prospective longitudinal study of 88 children with new-onset T1DM.
  • EEG recordings were performed at diagnosis, day 5, and 6 months post-diagnosis.
  • Clinical parameters and cognitive abilities were assessed, and encephalopathy was graded.

Main Results:

  • Abnormal EEG background slowing was more frequent in children with DKA at diagnosis (p=0.01).
  • EEG encephalopathy scores correlated with initial metabolic and hemodynamic parameters.
  • EEG scores at diagnosis did not correlate with medium-term cognitive function.

Conclusions:

  • DKA is associated with significant neurophysiological signs of brain dysfunction in pediatric T1DM at presentation.
  • EEG is sensitive for detecting encephalopathy in new-onset T1DM.
  • EEG has limited value in identifying children at risk for later cognitive deficits.
Abstract

Keywords:
DKAEEGbrain

Related Concept Videos

Diagnosing Acidosis and Alkalosis01:24

Diagnosing Acidosis and Alkalosis

Diagnosing acid-base imbalances involves systematically analyzing arterial blood samples, focusing on three key measurements: pH, bicarbonate (HCO3−) concentration, and carbon dioxide partial pressure (PCO2). This analysis follows a four-step process that helps identify the imbalance's underlying cause and nature.
First, the pH level is assessed to determine whether the blood pH is normal (7.35–7.45), low (acidosis), or high (alkalosis).
Next, the PCO2  and...
1.7K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
352
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K